Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet (London, England). 2019;394(10192):64–80.
Article
Google Scholar
Young LS, Dawson CW. Epstein-Barr virus and nasopharyngeal carcinoma. Chin J Cancer. 2014;33(12):581–90.
CAS
PubMed
PubMed Central
Google Scholar
Vokes EE, Liebowitz DN, Weichselbaum RR. Nasopharyngeal carcinoma. Lancet (London, England). 1997;350(9084):1087–91.
Article
CAS
Google Scholar
Zhang MX, Li J, Shen GP, Zou X, Xu JJ, Jiang R, et al. Intensity-modulated radiotherapy prolongs the
survival of patients with nasopharyngeal carcinoma compared with conventional
two-dimensional radiotherapy: A 10-year experience with a large cohort and long
follow-up. European journal of cancer (Oxford, England : 1990). 2015;51(17):2587–95.
Lee AW, Sze WM, Au JS, Leung SF, Leung TW, Chua DT, et al. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2005;61(4):1107–16.
Article
PubMed
Google Scholar
Leung TW, Tung SY, Sze WK, Wong FC, Yuen KK, Lui CM, et al. Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patterns. Head Neck. 2005;27(7):555–65.
Article
PubMed
Google Scholar
Au KH, Ngan RKC, Ng AWY, Poon DMC, Ng WT, Yuen KT, et al. Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study). Oral Oncol. 2018;77:16–21.
Article
CAS
PubMed
Google Scholar
Yi JL, Gao L, Huang XD, Li SY, Luo JW, Cai WM, et al. Nasopharyngeal carcinoma treated by radical radiotherapy alone: Ten-year experience of a single institution. Int J Radiat Oncol Biol Phys. 2006;65(1):161–8.
Article
PubMed
Google Scholar
Peng H, Wang SJ, Yang X, Lin J, Guo H, Liu M. Modified radical neck dissection for residual neck disease after radiotherapy of nasopharyngeal carcinoma. Auris Nasus Larynx. 2014;41(5):485–90.
Article
PubMed
Google Scholar
Wei WI, Lam KH, Ho CM, Sham JS, Lau SK. Efficacy of radical neck dissection for the control of cervical metastasis after radiotherapy for nasopharyngeal carcinoma. Am J Surg. 1990;160(4):439–42.
Article
CAS
PubMed
Google Scholar
Lin CY, Tsai ST, Jin YT, Yang MW, Yeh IC, Hsiao JR. Outcome of surgical management of persistent or recurrent neck mass in patients with nasopharyngeal carcinoma after radiotherapy. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 2008;265 Suppl 1:S69–74.
Li X, Lin C, Yan J, Chen Q, Sun X, Liu S, et al. Establishment of a prognostic scoring model for regional recurrent nasopharyngeal carcinoma after neck dissection. Cancer Biol Med. 2020;17(1):227–36.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shao J, Li Y, Gao H, Wu Q, Cui N, Zhang L, et al. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Cancer. 2004;100(6):1162–70.
Article
CAS
PubMed
Google Scholar
Chan A, Lo Y, Zee B, Chan L, Ma B, Leung S, et al. Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J Natl Cancer Inst. 2002;94(21):1614–9.
Article
CAS
PubMed
Google Scholar
Liu S, Sun X, Li X, Tang L, Chen Q, Lin H, et al. The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study. Cancer Commun (Lond). 2019;39(1):14.
Article
CAS
Google Scholar
Yeung DC, Yeung Z, Wong EW, Vlantis AC, Chan JY. Neck lymph node status on survival of regionally recurrent or persistent nasopharyngeal carcinoma. Sci Rep. 2020;10(1):1–8.
Article
Google Scholar
Chan R, Chan J. Impact of nodal ratio on survival in recurrent nasopharyngeal carcinoma. Head Neck. 2015;37(1):12–7.
Article
PubMed
Google Scholar
Park Y, Wang S, Lee J, Shin D, Kim I, Son S, et al. Metastatic lymph node status in the central compartment of papillary thyroid carcinoma: A prognostic factor of locoregional recurrence. Head & neck. 2016:E1172–6.
Ricarte-Filho J, Ganly I, Rivera M, Katabi N, Fu W, Shaha A, et al. Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension. Thyroid : official journal of the American Thyroid Association. 2012;22(6):575–84.
Feng Z, Xu Q, Wang C, Li J, Mao M, Li H, et al. Lymph node ratio is associated with adverse clinicopathological features and is a crucial nodal parameter for oral and oropharyngeal cancer. Sci Rep. 2017;7(1):6708.
Article
PubMed
PubMed Central
Google Scholar
Li X, Lin C, Yan J, Chen Q, Sun X, Liu S, et al. Establishment of a prognostic scoring model for regional recurrent nasopharyngeal carcinoma after neck dissection. Cancer Biol Med. 2020;17(1):227–36.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chan Y, Lee V, Chow V, To V, Wei W. Extracapsular lymph node spread in recurrent nasopharyngeal carcinoma. Laryngoscope. 2011;121(12):2576–80.
Article
PubMed
Google Scholar
Chan AT, Lo YM, Zee B, Chan LY, Ma BB, Leung SF, et al. Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J Natl Cancer Inst. 2002;94(21):1614–9.
Article
CAS
PubMed
Google Scholar
Lo YM, Chan AT, Chan LY, Leung SF, Lam CW, Huang DP, et al. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA. Can Res. 2000;60(24):6878–81.
CAS
Google Scholar
Lin JC, Wang WY, Chen KY, Wei YH, Liang WM, Jan JS, et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med. 2004;350(24):2461–70.
Article
CAS
PubMed
Google Scholar
Liu SL, Sun XS, Li XY, Tang LQ, Chen QY, Lin HX, et al. The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study. Cancer Commun (Lond). 2019;39(1):14.
Article
CAS
Google Scholar
Wei WI, Ho CM, Wong MP, Ng WF, Lau SK,Lam KHJAoOH, et al. Pathological basis of surgery in the management of postradiotherapy cervical metastasis in nasopharyngeal carcinoma. 1992;118(9):923–9.
CAS
Google Scholar
Wei WI, Mok VW. The management of neck metastases in nasopharyngeal cancer. Curr Opin Otolaryngol Head Neck Surg. 2007;15(2):99–102.
Article
PubMed
Google Scholar
Liu YP, Li H, You R, Li JB, Liu XK, Yang AK, et al. Surgery for isolated regional failure in nasopharyngeal carcinoma after radiation: Selective or comprehensive neck dissection. Laryngoscope. 2019;129(2):387–95.
Article
PubMed
Google Scholar
Chen J, Zhang L, Ji Q, Li D, Shen Q, Wang Z, et al. Selective neck dissection for neck residue of nasopharyngeal carcinoma: A prospective study. Journal of Cranio-Maxillofacial Surgery. 2015;43(8):1571–6.
Article
CAS
PubMed
Google Scholar
Khafif A, Ferlito A, Takes RP, Robbins KT. Is it necessary to perform radical neck dissection as a salvage procedure for persistent or recurrent neck disease after chemoradiotherapy in patients with nasopharyngeal cancer? : Springer; 2010.